Perioperative use of ECMO during double lung transplantation

ASAIO Journal

Volumn 55, Issue 3, 2009, Pages 255-258

  Xu, Lingfeng ^a   Li, Xin ^a   Xu, Meiyin ^a   Gao, Chengxin ^a   Zhu, Jinhong ^a   Ji, Bingyang ^b  

^a SHANGHAI CHEST HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-COAGULATION; BLOOD FLOW; CARDIOPULMONARY BYPASS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMORAL ARTERY; INFLAMMATORY RESPONSE; ISCHEMIA-REPERFUSION INJURY; LUNG DISEASE; LUNG TRANSPLANTATION; ONCOTIC PRESSURE; SURGICAL PROCEDURES;

BREAKWATERS; CENTRIFUGAL PUMPS; HYDRAULIC MACHINERY; MERCURY (METAL); OXYGENATION; OXYGENATORS; PULMONARY DISEASES; PUMPS; RESPIRATORY THERAPY; TRANSPLANTATION (SURGICAL);

BIOLOGICAL ORGANS;

ALBUMIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ASCENDING AORTA; BLOOD FLOW; CANNULATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DEATH; EXTRACORPOREAL OXYGENATION; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; HEART RIGHT ATRIUM; HEMATOCRIT; HEMODYNAMICS; HUMAN; INFLAMMATION; INTUBATION; ISCHEMIA; LUNG DISEASE; LUNG TRANSPLANTATION; MALE; ONCOTIC PRESSURE; PERFUSION; PERIOPERATIVE PERIOD; PUMP; REPERFUSION INJURY; THORAX DRAINAGE; TREATMENT DURATION; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PERIOPERATIVE CARE;

EID: 67650403391     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3181a05795     Document Type: Article

References (18)

1. Hosenpud JD, Bennett LE, Berkley MK, et al: Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 351: 24-27, 1998.
2. Hasan A, Corris PA, Healy M, et al: Bilateral sequential lung transplantation for end stage septic lung disease. Thorax 50: 565-566, 1995.
3. Gammie JS, Lee JC, Pham SM, et al: Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double lung transplantation. J Thorac Cardiovasc Surg 115: 990-997, 1998.
4. Kesten S, de Hoyas A, Chaparro C, et al: Aprotinin reduces blood loss in lung transplant recipients. Ann Thorac Surg 59: 877-879, 1995.
5. Fischer S, Bohn D, Rycus P, et al: Extracorporeal membrane oxygenation (ECMO) for primary graft dysfunction (PGD) after lung transplantation: Analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant 26: 472-477, 2007.
6. Mason DP, Boffa DJ, Murthy SC, et al: Extended use of extracorporeal membrane oxygenation after lung transplantation. J Thorac Cardiovasc Surg 132: 954-960, 2006.
7. Lick SD, Brown PS Jr, Kurusz M, et al: Technique of controlled reperfusion of the transplanted lung in humans. Ann Thorac Surg 69: 910-912, 2000.
8. Fullerton DA, Mitchell MB, Jones DN, et al: Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow. J Thorac Cardiovasc Surg 111: 190-197, 1996.
9. DeLima NF, Binns OA, Buchanan SA, et al: Euro-Collins solution exacerbates lung injury in the setting of high-flow reperfusion. J Thorac Cardiovasc Surg 112: 111-116, 1996.
10. Khan SU, Salloum J, O'Donovan PB, et al: Acute pulmonary edema after transplantation: The pulmonary reimplantation response. Chest 116: 187-194, 1999.
11. Sakamoto T, Yamashita C, Okada M: Efficacy of initial controlled perfusion pressure for ischemia-reperfusion injury in a 24-hour preserved lung. Ann Thorac Cardiovasc Surg 5: 21-26, 1999.
12. Halldorsson AO, Kronon M, Allen BS, et al: Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation. Ann Thorac Surg 66: 877-884, 1998.
13. Bhabra MS, Hopkinson DN, Shaw TE, Hooper TL: Critical importance of the first 10 minutes of lung graft reperfusion after hypothermic storage. Ann Thorac Surg 61: 1631-1635, 1996.
14. Halldorsson A, Kronon M, Allen BS, et al: Controlled reperfusion after lung ischemia: Implications for improved function after lung transplantation. J Thorac Cardiovasc Surg 115: 415-424, 1998.
15. Ko WJ, Chen YS, Lee YC: Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Artif Organs 25: 607-612, 2001.
16. Wendel HP, Scheule AM, Eckstein FS, Ziemer G: Haemocompatibility of paediatric membrane oxygenators with heparincoated surfaces. Perfusion 14: 21-28, 1999.
17. Lundblad R, Moen O, Fosse E: Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg 63: 1361-1367, 1997.
18. Bittner HB, Binner C, Lehmann S, et al: Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg 31: 462-467, 2007.